Analytical Chemist - Antibody-Drug Conjugates at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

BS or MS in Analytical Chemistry, Biochemistry, Chemistry, or a related field
Experience with chromatographic separations and/or spectroscopic methods and methods for the analysis of antibody-drug conjugates (preferred)
Experience with method validation and transfer (preferred)
Demonstration of scientific and people leadership skills (preferred)
Effective oral and written communication skills
The ability to work productively in an interdisciplinary team environment
Ability to balance multiple activities, prioritize and handle ambiguity

Responsibilities

Engage with scientists across Eli Lilly’s Development and Manufacturing organizations to develop and validate robust analytical methods
Identify and exploit new scientific concepts, strong problem-solving skills, and be self-motivated to contribute across multiple projects
Develop analytical methods to support progression of the antibody-drug conjugate portfolio
Evaluate and/or implement new analytical technologies/methods to advance Lilly's current analytical capabilities for bioproduct testing with a focus on state-of-the-art separation sciences capabilities
Generate key data and information applying HPLC, UHPLC, capillary electrophoresis, LCMS and/or other instrumental analysis techniques
Strong written and verbal communication to speak to both technical and business-related implications of your work

Skills

Analytical Chemistry

Antibody-Drug Conjugates

HPLC

Mass Spectrometry

Spectroscopy

Chromatography

Monoclonal Antibodies

Bioproduct Development

Pharmaceutical Analysis

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free